Factor XIII concentrate: Difference between revisions

Factor XIII concentrate
	Adult Indications & Dosage
	Pediatric Indications & Dosage
	Contraindications
	Warnings & Precautions
	Adverse Reactions
	Drug Interactions
	Use in Specific Populations
	Administration & Monitoring
	Overdosage
	Pharmacology
	Clinical Studies
	How Supplied
	Images
	Patient Counseling Information
	Precautions with Alcohol
	Brand Names
	Look-Alike Names

VisualWikitext

Revision as of 18:14, 27 April 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Factor XIII concentrate is a hemostatic that is FDA approved for the treatment of congenital Factor XIII deficiency. Common adverse reactions include joint inflammation, hypersensitivity, rash, pruritus, erythema, hematoma, arthralgia, headache, elevated thrombin-antithrombin levels, and increased blood lactate dehydrogenase.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

Corifact is a Factor XIII concentrate indicated for adult and pediatric patients with congenital Factor XIII deficiency for:

Routine prophylactic treatment Peri-operative management of surgical bleeding

Dosage

40 International Units (IU) per kg body weight at a rate not to exceed 4 mL per minute Adjust dose ±5 IU per kg to maintain 5% to 20% trough level of FXIII activity as provided in the example below

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Factor XIII concentrate in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Factor XIII concentrate in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Indications

Corifact is a Factor XIII Concentrate indicated for routine prophylactic treatment and peri-operative management of surgical bleeding in adult and pediatric patients with congenital FXIII deficiency.

Dosage

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition1

Developed by:

Class of Recommendation:

Strength of Evidence:

Dosing Information

Dosage

Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Factor XIII concentrate in pediatric patients.

Non–Guideline-Supported Use

Condition1

Dosing Information

Dosage

Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Factor XIII concentrate in pediatric patients.

Contraindications

Condition1

Warnings

Description

Precautions

Description

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Factor XIII concentrate in the drug label.

Body as a Whole

Cardiovascular

Digestive

Endocrine

Hematologic and Lymphatic

Metabolic and Nutritional

Musculoskeletal

Neurologic

Respiratory

Skin and Hypersensitivy Reactions

Special Senses

Urogenital

Miscellaneous

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Factor XIII concentrate in the drug label.

Body as a Whole

Cardiovascular

Digestive

Endocrine

Hematologic and Lymphatic

Metabolic and Nutritional

Musculoskeletal

Neurologic

Respiratory

Skin and Hypersensitivy Reactions

Special Senses

Urogenital

Miscellaneous

Drug Interactions

Drug

Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

Pregnancy Category

Pregnancy Category (AUS):

Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Factor XIII concentrate in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Factor XIII concentrate during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Factor XIII concentrate with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Factor XIII concentrate with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Factor XIII concentrate with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Factor XIII concentrate with respect to specific gender populations.

Race

There is no FDA guidance on the use of Factor XIII concentrate with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Factor XIII concentrate in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Factor XIII concentrate in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Factor XIII concentrate in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Factor XIII concentrate in patients who are immunocompromised.

Administration and Monitoring

Administration

Oral

Intravenous

Monitoring

There is limited information regarding Monitoring of Factor XIII concentrate in the drug label.

Description

IV Compatibility

There is limited information regarding IV Compatibility of Factor XIII concentrate in the drug label.

Overdosage

Acute Overdose

Signs and Symptoms

Description

Management

Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Factor XIII concentrate in the drug label.

Pharmacology

There is limited information regarding Factor XIII concentrate Pharmacology in the drug label.

Mechanism of Action

Structure

File:Factor XIII concentrate01.png

This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Factor XIII concentrate in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Factor XIII concentrate in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Factor XIII concentrate in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Factor XIII concentrate in the drug label.

How Supplied

Storage

There is limited information regarding Factor XIII concentrate Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Factor XIII concentrate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Factor XIII concentrate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Factor XIII concentrate in the drug label.

Precautions with Alcohol

Alcohol-Factor XIII concentrate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

®^[1]

Look-Alike Drug Names

A® — B®^[2]

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

↑ Empty citation (help)
↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject:

 |Page Name=Factor XIII concentrate
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Factor XIII concentrate
 |Label Name=Factor XIII concentrate11.png

}}

{{#subobject:

 |Label Page=Factor XIII concentrate
 |Label Name=Factor XIII concentrate11.png

}}

[1] Empty citation (help)

[www.ismp.org-2] "http://www.ismp.org". External link in |title= (help)

[1]

[2]

@@ Line 1: / Line 1: @@
 {{DrugProjectFormSinglePage
 |authorTag={{RB}}
+|genericName=Factor XIII concentrate
 |aOrAn=a
+|drugClass=hemostatic
 |indicationType=treatment
-|hasBlackBoxWarning=Yes
+|indication=congenital Factor XIII deficiency
-|adverseReactions=<!--Black Box Warning-->
+|adverseReactions= joint inflammation, hypersensitivity, rash, pruritus, erythema, hematoma, arthralgia, headache, elevated thrombin-antithrombin levels, and increased blood lactate dehydrogenase
+<!--Black Box Warning-->
 |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
 |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
-* Content
 <!--Adult Indications and Dosage-->
 <!--FDA-Labeled Indications and Dosage (Adult)-->
-|fdaLIADAdult======Condition1=====
+|fdaLIADAdult=====Indications====
+Corifact is a Factor XIII concentrate indicated for adult and pediatric patients with congenital Factor XIII deficiency for:
-* Dosing Information
-:* Dosage
-=====Condition2=====
-* Dosing Information
-:* Dosage
-=====Condition3=====
-* Dosing Information
-:* Dosage
-=====Condition4=====
-* Dosing Information
-:* Dosage
-<!--Off-Label Use and Dosage (Adult)-->
-<!--Guideline-Supported Use (Adult)-->
+Routine prophylactic treatment
-|offLabelAdultGuideSupport======Condition1=====
+Peri-operative management of surgical bleeding
-* Developed by:
+====Dosage====
-* Class of Recommendation:
+International Units (IU) per kg body weight at a rate not to exceed 4 mL per minute
+Adjust dose ±5 IU per kg to maintain 5% to 20% trough level of FXIII activity as provided in the example below
-* Strength of Evidence:
+[[File:Fac VIII Dosage.png|none|400px]]
-* Dosing Information
-:* Dosage
+|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
-=====Condition2=====
-There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 <!--Non–Guideline-Supported Use (Adult)-->
-|offLabelAdultNoGuideSupport======Condition1=====
+|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 <!--Pediatric Indications and Dosage-->
 <!--FDA-Labeled Indications and Dosage (Pediatric)-->
-|fdaLIADPed======Condition1=====
+|fdaLIADPed=====Indications====
+Corifact is a Factor XIII Concentrate indicated for routine prophylactic treatment and peri-operative management of surgical bleeding in adult and pediatric patients with congenital FXIII deficiency.
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
-<!--Off-Label Use and Dosage (Pediatric)-->
+====Dosage====
-<!--Guideline-Supported Use (Pediatric)-->
 |offLabelPedGuideSupport======Condition1=====